Epigenetic Silencing of Mir-338-3p Contributes to Tumorigenicity in Gastric Cancer by Targeting SSX2IP.

Pu Li,Xuehua Chen,Liping Su,Chenglong Li,Qiaoming Zhi,Beiqin Yu,Hong Sheng,Junqing Wang,Runhua Feng,Qu Cai,Jianfang Li,Yingyan Yu,Min Yan,Bingya Liu,Zhenggang Zhu
DOI: https://doi.org/10.1371/journal.pone.0066782
IF: 3.7
2013-01-01
PLoS ONE
Abstract:MicroRNA has been recently recognized as playing a prominent role in tumorigenesis and metastasis. Here, we report that miR-338-3p was epigenetically silenced in gastric cancer, and its down-regulation was significantly correlated with gastric cancer clinicopathological features. Strikingly, restoring miR-338-3p expression in SGC-7901 gastric cancer cells inhibited proliferation, migration, invasion and tumorigenicity in vitro and in vivo, at least partly through inducing apoptosis. Furthermore, we demonstrate the oncogene SSX2IP is a target of miR-338-3p. We propose that miR-338-3p functions as a tumor suppressor in gastric cancer, and the methylation status of its CpG island could serve as a potential diagnostic marker for gastric cancer.
What problem does this paper attempt to address?